Denali Therapeutics (FRA:4DN) YoY Rev. per Sh. Growth : -100.00% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Denali Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Denali Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was -100.00%.

Denali Therapeutics's Revenue per Share for the three months ended in Mar. 2024 was €0.00.

Denali Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Denali Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denali Therapeutics YoY Rev. per Sh. Growth Chart

Denali Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-79.53

875.30

-85.54

130.51

170.34

Denali Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-23.08	376.73	-68.97	-100.00	-100.00

Denali Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Denali Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(2.206	-	0.816)	/	\| 0.816 \|
=	170.34 %

Denali Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=	(Revenue per Share (Q: Mar. 2024 )	-	Revenue per Share (Q: Mar. 2023 ))	/	\| Revenue per Share (Q: Mar. 2023 )) \|
=	(0	-	0.24)	/	\| 0.24 \|
=	-100.00 %

Denali Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Denali Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Denali Therapeutics (FRA:4DN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Denali Therapeutics Inc (FRA:4DN) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

DNLI:USA 4DN:Germany

Address

161 Oyster Point Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.denalitherapeutics.com

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Denali Therapeutics (FRA:4DN) Headlines

No Headlines